Sorafenib-Induced Eruption Mimicking Erythema Multiforme

JAMA Dermatol. 2016 Feb;152(2):227-8. doi: 10.1001/jamadermatol.2015.2930.

Authors

Dominique C Pichard¹, Adela R Cardones², Emily Y Chu³, William L Dahut⁴, Heidi H Kong¹

Affiliations

¹ Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
² Department of Dermatology, Duke University Medical Center, Durham, North Carolina.
³ Department of Dermatology, University of Pennsylvania, Philadelphia.
⁴ Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Drug Eruptions / diagnosis*
Drug Eruptions / etiology
Drug Eruptions / pathology
Erythema Multiforme / diagnosis*
Erythema Multiforme / pathology
Humans
Male
Niacinamide / administration & dosage
Niacinamide / adverse effects
Niacinamide / analogs & derivatives*
Phenylurea Compounds / administration & dosage
Phenylurea Compounds / adverse effects*
Sorafenib

Substances

Antineoplastic Agents
Phenylurea Compounds
Niacinamide
Sorafenib

Grants and funding

Z01 BC010940-01/Intramural NIH HHS/United States